相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Influence of the blood-CSF-barrier function on S100B in neurodegenerative diseases
P. Steinacker et al.
ACTA NEUROLOGICA SCANDINAVICA (2013)
CSF biomarker variability in the Alzheimer's Association quality control program
Niklas Mattsson et al.
ALZHEIMERS & DEMENTIA (2013)
CSF Biomarkers for Amyloid and Tau Pathology in Alzheimer's Disease
Hanna Rosenmann
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
The Creutzfeldt-Jakob disease (CJD) neurological status scale: a new tool for evaluation of disease severity and progression
O. S. Cohen et al.
ACTA NEUROLOGICA SCANDINAVICA (2011)
Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel
Zeev Meiner et al.
JOURNAL OF NEUROLOGY (2011)
Cerebrospinal Fluid Biomarkers in Alzheimer's Disease Families with PSEN1 Mutations
Juan Fortea et al.
NEURODEGENERATIVE DISEASES (2011)
Use of cerebrospinal fluid biomarkers in diagnosis of dementia across Europe
J. Hort et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity
Kaisa Samgard et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Correlation between Cognitive Impairment and CSF Biomarkers in Amnesic MCI, non-Amnesic MCI, and Alzheimer's Disease
Andreas Haldenwanger et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
Tero Tapiola et al.
ARCHIVES OF NEUROLOGY (2009)
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease
I. Zerr et al.
BRAIN (2009)
Increased Total Tau But Not Amyloid-beta(42) in Cerebrospinal Fluid Correlates with Short-Term Memory Impairment in Alzheimer's Disease
Yuh-Te Lin et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies
Anna Ladogana et al.
JOURNAL OF NEUROLOGY (2009)
MR Imaging of Familial Creutzfeldt-Jakob Disease: A Blinded and Controlled Study
R. K. Fulbright et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease
C. Haense et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
Brit Mollenhauer et al.
EXPERIMENTAL NEUROLOGY (2008)
CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment
Alessandro Stefani et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Brain-derived proteins in the CSF, do they correlate with brain pathology in CJD?
Constanze Boesenberg-Grosse et al.
BMC NEUROLOGY (2006)
14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan
K Satoh et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2006)
Cerebrospinal fluid TAU protein and amyloid β42 in mild cognitive impairment:: prediction of progression to Alzheimer's disease and correlation with the neuropsychological examination
A Ivanoiu et al.
NEUROCASE (2005)
A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease
B Van Everbroeck et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Relationships among cerebrospinal fluid biomarkers in dementia of the Alzheimer type
JG Csernansky et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2002)
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease
M Otto et al.
NEUROLOGY (2002)
The FAB - A frontal assessment battery at bedside
B Dubois et al.
NEUROLOGY (2000)
Decreased β-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
M Otto et al.
NEUROLOGY (2000)
分享论文
